Xiaoni Wang1, Mingyan Zhao1, Li Lin1, Ying Han1,2,3. 1. Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China. 2. National Clinical Research Center for Geriatric Disorders, Beijing, China. 3. Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing, China.
Abstract
Background: Accumulating evidence has demonstrated that plasma β-amyloid (Aβ) levels are useful biomarkers to reflect brain amyloidosis and gray matter structure, but little is known about their correlation with subclinical white matter (WM) integrity in individuals at risk of Alzheimer's disease (AD). Here, we investigated the microstructural changes in WM between subjects with low and high plasma Aβ levels among individuals with subjective cognitive decline (SCD). Methods: This study included 142 cognitively normal individuals with SCD who underwent a battery of neuropsychological tests, plasma Aβ measurements, and diffusion tensor imaging (DTI) based on the Sino Longitudinal Study on Cognitive Decline (SILCODE). Using tract-based spatial statistics (TBSS), we compared fractional anisotropy (FA), and mean diffusivity (MD) in WM between subjects with low (N = 71) and high (N = 71) plasma Aβ levels (cut-off: 761.45 pg/ml for Aβ40 and 10.74 pg/ml for Aβ42). Results: We observed significantly decreased FA and increased MD in the high Aβ40 group compared to the low Aβ40 group in various regions, including the body, the genu, and the splenium of the corpus callosum; the superior longitudinal fasciculus; the corona radiata; the thalamic radiation; the external and internal capsules; the inferior fronto-occipital fasciculus; and the sagittal stratum [p < 0.05, familywise error (FWE) corrected]. Average FA values were associated with poor performance on executive and memory assessments. No significant differences were found in either MD or FA between the low and high Aβ42 groups. Conclusion: Our results suggest that a correlation exists between WM integrity and plasma Aβ40 levels in individuals with SCD.
Background: Accumulating evidence has demonstrated that plasma β-amyloid (Aβ) levels are useful biomarkers to reflect brain amyloidosis and gray matter structure, but little is known about their correlation with subclinical white matter (WM) integrity in individuals at risk of Alzheimer's disease (AD). Here, we investigated the microstructural changes in WM between subjects with low and high plasma Aβ levels among individuals with subjective cognitive decline (SCD). Methods: This study included 142 cognitively normal individuals with SCD who underwent a battery of neuropsychological tests, plasma Aβ measurements, and diffusion tensor imaging (DTI) based on the Sino Longitudinal Study on Cognitive Decline (SILCODE). Using tract-based spatial statistics (TBSS), we compared fractional anisotropy (FA), and mean diffusivity (MD) in WM between subjects with low (N = 71) and high (N = 71) plasma Aβ levels (cut-off: 761.45 pg/ml for Aβ40 and 10.74 pg/ml for Aβ42). Results: We observed significantly decreased FA and increased MD in the high Aβ40 group compared to the low Aβ40 group in various regions, including the body, the genu, and the splenium of the corpus callosum; the superior longitudinal fasciculus; the corona radiata; the thalamic radiation; the external and internal capsules; the inferior fronto-occipital fasciculus; and the sagittal stratum [p < 0.05, familywise error (FWE) corrected]. Average FA values were associated with poor performance on executive and memory assessments. No significant differences were found in either MD or FA between the low and high Aβ42 groups. Conclusion: Our results suggest that a correlation exists between WM integrity and plasma Aβ40 levels in individuals with SCD.
Authors: Susumu Mori; Kenichi Oishi; Hangyi Jiang; Li Jiang; Xin Li; Kazi Akhter; Kegang Hua; Andreia V Faria; Asif Mahmood; Roger Woods; Arthur W Toga; G Bruce Pike; Pedro Rosa Neto; Alan Evans; Jiangyang Zhang; Hao Huang; Michael I Miller; Peter van Zijl; John Mazziotta Journal: Neuroimage Date: 2008-01-03 Impact factor: 6.556
Authors: Rebecca E Amariglio; Elizabeth C Mormino; Alison C Pietras; Gad A Marshall; Patrizia Vannini; Keith A Johnson; Reisa A Sperling; Dorene M Rentz Journal: Neurology Date: 2015-06-05 Impact factor: 9.910
Authors: Laibaik Park; Ping Zhou; Kenzo Koizumi; Sleiman El Jamal; Mary Lou Previti; William E Van Nostrand; George Carlson; Costantino Iadecola Journal: Stroke Date: 2012-11-29 Impact factor: 7.914
Authors: Melinda C Power; Dan Su; Aozhou Wu; Robert I Reid; Clifford R Jack; David S Knopman; Joe Coresh; Juebin Huang; Kejal Kantarci; A Richey Sharrett; Rebecca G Gottesman; Mike E Griswold; Thomas H Mosley Journal: Neurobiol Aging Date: 2019-08-29 Impact factor: 4.673
Authors: Reisa A Sperling; Dorene M Rentz; Keith A Johnson; Jason Karlawish; Michael Donohue; David P Salmon; Paul Aisen Journal: Sci Transl Med Date: 2014-03-19 Impact factor: 17.956
Authors: Pierre Bellec; Sébastien Lavoie-Courchesne; Phil Dickinson; Jason P Lerch; Alex P Zijdenbos; Alan C Evans Journal: Front Neuroinform Date: 2012-04-03 Impact factor: 4.081
Authors: Jeremy F Strain; Robert X Smith; Helen Beaumont; Catherine M Roe; Brian A Gordon; Shruti Mishra; Babatunde Adeyemo; Jon J Christensen; Yi Su; John C Morris; Tammie L S Benzinger; Beau M Ances Journal: Neurology Date: 2018-06-29 Impact factor: 9.910
Authors: Suzanne E Schindler; James G Bollinger; Vitaliy Ovod; Kwasi G Mawuenyega; Yan Li; Brian A Gordon; David M Holtzman; John C Morris; Tammie L S Benzinger; Chengjie Xiong; Anne M Fagan; Randall J Bateman Journal: Neurology Date: 2019-08-01 Impact factor: 11.800
Authors: Shannon L Risacher; Noelia Fandos; Judith Romero; Ian Sherriff; Pedro Pesini; Andrew J Saykin; Liana G Apostolova Journal: Alzheimers Dement (Amst) Date: 2019-07-26